BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31002453)

  • 1. The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes.
    Gonna H; Ray KK
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 1():6-16. PubMed ID: 31002453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual cardiovascular risk among people with diabetes.
    Dash S; Leiter LA
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 1():28-38. PubMed ID: 31002458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
    Taskinen MR; Borén J
    Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia in type 2 diabetes mellitus.
    Gadi R; Samaha FF
    Curr Diab Rep; 2007 Jun; 7(3):228-34. PubMed ID: 17547840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urban-rural differences in atherogenic dyslipidaemia (URDAD Study): a retrospective report on diabetic and non-diabetic subjects of Northern India.
    Agrawal P; Reddy VS; Madaan H; Patra SK; Garg R
    J Health Popul Nutr; 2014 Sep; 32(3):494-502. PubMed ID: 25395912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Bilz S
    Ther Umsch; 2017; 74(8):445-453. PubMed ID: 29461147
    [No Abstract]   [Full Text] [Related]  

  • 11. Catabolism of lipoproteins and metabolic syndrome.
    Therond P
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):366-71. PubMed ID: 19474714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid triad, or how to reduce residual cardiovascular risk?
    Girard-Mauduit S
    Ann Endocrinol (Paris); 2010 Mar; 71(2):89-94. PubMed ID: 20303470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?
    Taskinen MR
    Diabetes Res Clin Pract; 2003 Jul; 61 Suppl 1():S19-26. PubMed ID: 12880691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives.
    Chapman MJ
    Atherosclerosis; 2003 Nov; 171(1):1-13. PubMed ID: 14642400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ; Lundman P; Tardif JC
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?
    Rizzo M; Barylski M; Rizvi AA; Montalto G; Mikhailidis DP; Banach M
    Curr Pharm Des; 2013; 19(21):3858-68. PubMed ID: 23286436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol].
    Brea Hernando ÁJ
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():3-6. PubMed ID: 25043539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.
    Chehade JM; Gladysz M; Mooradian AD
    Drugs; 2013 Mar; 73(4):327-39. PubMed ID: 23479408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies for diabetic dyslipidaemia.
    Bell DS; Al Badarin F; O'Keefe JH
    Diabetes Obes Metab; 2011 Apr; 13(4):313-25. PubMed ID: 21205114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.